Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation …
Over the last 12 months, insiders at Ainos, Inc. have bought $0 and sold $0 worth of Ainos, Inc. stock.
On average, over the past 5 years, insiders at Ainos, Inc. have bought $400,388 and sold $300,000 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 61,157 shares for transaction amount of $48,559 was made by lee ting-chuan (director) on 2023‑04‑26.
2023-04-26 | director | 61,157 0.7485% | $0.79 | $48,559 | -25.61% | |||
2023-04-19 | Sale | 10 percent owner | 400,000 4.6242% | $0.75 | $300,000 | -22.86% | ||
2021-12-21 | CHIEF EXECUTIVE OFFICER | 333,986 2.574% | $0.50 | $166,993 | -44.82% | |||
2021-12-20 | director | 142,918 1.1015% | $0.50 | $71,459 | -32.00% | |||
2021-12-06 | director | 4M 15.414% | $0.25 | $1M | -15.56% | |||
2021-12-06 | director | 150,000 4.6242% | $2.00 | $300,000 | -15.56% | |||
2020-10-12 | President,Chairman,CEO,CFO | 400 0.0009% | $0.14 | $56 | +216.44% | |||
2020-10-09 | President,Chairman,CEO,CFO | 300 0.0006% | $0.14 | $41 | +253.33% | |||
2020-10-08 | President,Chairman,CEO,CFO | 400 0.0008% | $0.13 | $52 | +307.69% | |||
2020-10-05 | President,Chairman,CEO,CFO | 200 0.0007% | $0.22 | $44 | +112.00% | |||
2020-09-28 | President,Chairman,CEO,CFO | 300 0.0008% | $0.18 | $54 | +140.42% | |||
2020-09-22 | President,Chairman,CEO,CFO | 200 0.0006% | $0.20 | $40 | +163.73% | |||
2020-09-21 | President,Chairman,CEO,CFO | 800 0.002% | $0.16 | $128 | +222.57% | |||
2020-09-17 | President,Chairman,CEO,CFO | 100 0.0003% | $0.22 | $22 | +117.51% | |||
2020-09-11 | President,Chairman,CEO,CFO | 100 0.0003% | $0.18 | $18 | +116.55% | |||
2020-09-03 | President,Chairman,CEO,CFO | 300 0.001% | $0.21 | $63 | +142.86% | |||
2020-09-02 | President,Chairman,CEO,CFO | 200 0.0006% | $0.21 | $42 | +124.38% | |||
2020-08-27 | President,Chairman,CEO,CFO | 100 0.0003% | $0.21 | $21 | +120.77% | |||
2020-08-24 | President,Chairman,CEO,CFO | 100 0.0003% | $0.21 | $21 | +137.50% | |||
2020-08-19 | President,Chairman,CEO,CFO | 300 0.001% | $0.21 | $63 | +104.55% |
Paul Tibbits | 9417696 68.0528% | $0.45 | 40 | 0 | ||
chang wen-han | director | 4000000 28.9042% | $0.45 | 1 | 0 | |
MUELLER PETER ROBERT | COO & DIRECTOR OF RESEARCH | 1163186 8.4053% | $0.45 | 3 | 1 | |
CHEN STEPHEN T | President,Chairman,CEO,CFO | 783000 5.658% | $0.45 | 351 | 3 | |
CUMMINS JOSEPH M | PRES,CEO,CHAIRMAN OF THE BOARD | 781724 5.6488% | $0.45 | 7 | 47 |